Showing results (401-410 of 418) with videos related to

Sort By:
Pageof 42
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 1, 1998
Standardizing the classification and description of follicular unit transplantation and mini-micrografting techniques. The American Society for Dermatologic Surgery, IncR M Bernstein, W R Rassman, D Seager, et al.
Cell Death and Differentiation|May 26, 2026
Fatty acid channelling into triglycerides and oxylipins drives ferroptosis resistance during oncogenic BRAF-induced senescenceMarkus S Hess, Kamal M Al-Shami, Carolina Dehesa Caballero, et al.
Bioorganic & Medicinal Chemistry Letters|March 16, 2013
N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: strategies to eliminate reactive metabolitesSajiv K Nair, Jean J Matthews, Stephan J Cripps, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2024
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2026
PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomySophia Scharl, Reinhard Thamm, Constantinos Zamboglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2023
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/mlNantia Solomonidou, Daphnie Germanou, Iosif Strouthos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapySimon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
JAMA Network Open|May 23, 2023
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate CancerConstantinos Zamboglou, Jan C Peeken, Ali Janbain, et al.
Pageof 42